Profiling the impact of two JAK inhibitors in a pre-clinical model of allergic asthma Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020
Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations Source: Eur Respir J 2016; 47: 783-791 Year: 2016
A phosphatidylinositol 3-kinase Inhibitor strongly suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015
Leukotriene receptor antagonists for allergic rhino-sinusitis: a systematic review and meta-analysis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
RP6503, a novel and selective PI3K δ/gamma inhibitor, potentiates the effect of steroids in pre-clinical models of COPD Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-a and -? selectivity, suppresses COPD inflammation Source: Eur Respir J, 50 (4) 1700188; 10.1183/13993003.00188-2017 Year: 2017
Role of ras protoncogene in survival of patients with lung cancer: a systematic literature review and meta-analysis Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015
Effect of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i) on markers of inflammation in COPD patients Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
ONX0912, a novel proteasome inhibitor for the treatment of lung fibrosis? Source: Annual Congress 2012 - New drug targets and pre-clinical models for respiratory diseases Year: 2012
Anti IL-17 with or without Rho kinase inhibitor in mice with chronic allergic pulmonary inflammation Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
High-altitude alpine therapy and lung function in asthma: systematic review and meta-analysis Source: ERJ Open Res 2016: 00097-2015 Year: 2016
Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019
Association between cyclooxygenase inhibitor use and efficacy of immunotherapy: a retrospective study Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Inhibitors of PDE4 delay eosinophil apoptosis Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
In vitro and in vivo pharmacological profile of RP6503, a novel dual PI3K Δ/gamma inhibitor, in pulmonary disease systemsSource: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013
Effects of CHF6297, a potent and selective p38a MAPK inhibitor, in murine models of steroid resistant lung inflammation Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017
The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Inhibition of c-kit tyrosine kinase by sunitinib alleviates airway remodeling in a mouse model of chronic asthma Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009